MZ101 ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
210Single Ventricle1

210. Single Ventricle


Clinical trials : 49 Drugs : 53 - (DrugBank : 23) / Drug target genes : 32 - Drug target pathways : 67
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03430583
(ClinicalTrials.gov)
February 20, 201822/1/2018Evaluation of Fontan-Associated Liver DiseaseImaging and Biomarker Evaluation of Hepatic Stiffness in Children Enrolled in the Fontan Udenafil Exercise Longitudinal StudySingle Ventricle Heart DiseaseDrug: MZ101Mezzion Pharma Co. LtdNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting12 YearsN/AAll100United States;Canada